ClinicalTrials.Veeva

Menu

PFDD Versus PFDRT in Chiari Decompression Surgery

Capital Medical University logo

Capital Medical University

Status

Enrolling

Conditions

Tonsillectomy
Chiari Malformation Type I

Treatments

Procedure: PFDD with tonsillar resection/reduction
Procedure: Posterior fossa decompression with duraplasty

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether a posterior fossa decompression and duraplasty with or without tonsil manipulation results in better patient outcomes with fewer complications and improved quality of life in those who have Chiari malformation type I and syringomyelia.

Full description

Participants with Chiari Malformation type I and syringomyelia will be randomized to either have a posterior fossa decompression and duraplasty with or without tonsil manipulation. The participant will then return to the neurosurgeon's office at the following time points which are consistent with standard of care practice: 3-6 months, 12 and 24 months. At these visits, the clinician will complete a physical exam and the participant will report on the prognosis of symptoms and complete questionnaires. A spine MRI will be performed 3-6 months, 12 and 24 months after the decompression.

Enrollment

352 estimated patients

Sex

All

Ages

14 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥14 years old
  • Chiari malformation type I ≥5 mm tonsillar ectopia
  • a syrinx with a width > 50% of the cross-sectional diameter of the spinal cord , and a length of at least 2 cervical and/or thoracic vertebral segments.
  • MRI of the brain and cervical and thoracic spine are required prior to surgery and must be available to be shared with the Data Coordinating Center

Exclusion criteria

  • included one or more of the following preexisting conditions: hydrocephalus; tumor; brain trauma; stroke; meningitis; abscess;
  • other congenital anomalies of the brain or skull base; vertebral anomalies (i.e., Klippel-Feil, atlas assimilation, etc.);
  • degenerative or demyelinating disease;
  • CM-I without syringomyelia;
  • syringomyelia with cerebellar tonsils in a normal position;
  • fibromyalgia;
  • chronic fatigue syndrome;
  • prior posterior fossa surgery.
  • Unable to share pre-decompression MRI of the brain and spine Patients who do not wish to participate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

352 participants in 2 patient groups

Posterior fossa decompression with duraplasty
Experimental group
Description:
The bone is removed from the suboccipital region of the skull and Cervical 1 lamina so the constricting epidural band can be resected. Then, the dura is opened. Microsurgical dissection is performed and the dura is sewn closed.
Treatment:
Procedure: Posterior fossa decompression with duraplasty
PFDD with tonsillar resection/reduction
Experimental group
Description:
The bone is removed from the suboccipital region of the skull and Cervical 1 lamina so the constricting epidural band can be resected. Then, the dura is opened and herniated tonsil will be manipulated. Microsurgical dissection is performed and the dura is sewn closed.
Treatment:
Procedure: PFDD with tonsillar resection/reduction

Trial contacts and locations

1

Loading...

Central trial contact

fengzeng jian, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems